Category: Biopsy

What makes one prostate biopsy better than another? It often comes down to two things: how clearly the doctor can see the target, and how many needles it takes to reach it. Real-time MRI guidance can pinpoint a suspicious lesion with just a few samples, while older methods rely on more needles and more guesswork. Accuracy and safety both hang on that choice. keep reading

As many as 75% of PSA tests come back falsely positive, and for years that single number sent men straight to a needle biopsy with all its risks. Today, noninvasive biomarker tests in blood and urine, paired with mpMRI, are reshaping who truly needs the procedure and who can safely be spared the discomfort and the worry. keep reading

A high PSA result sounds alarming but it doesn't automatically mean cancer. Other factors can raise PSA, and until recently, the only way to know more was a biopsy. Now, two major breakthroughs are reshaping prostate cancer screening in ways that protect men from unnecessary procedures. keep reading

MRI-based diagnosis offers a more accurate and less invasive path for prostate cancer detection than traditional methods. By identifying clinically significant tumors before biopsy, the MRI pathway helps prevent overtreatment while safeguarding quality of life. keep reading

Recent research uncovers substantial agreement between MRI-targeted prostate biopsy results and surgical specimens, offering fresh insight into biopsy accuracy for prostate cancer. Rates of concordance are highest for more aggressive disease, yet lower for lower-grade findings. keep reading

Research indicates that regular mpMRI scans and PSA density checks might allow some prostate cancer patients on active surveillance to delay confirmatory biopsy at one year. While the evidence is promising, experts say more study is needed before changing established protocols. keep reading

Recent studies are questioning whether prostatectomies can sometimes proceed without a prior biopsy, thanks to high-precision imaging techniques like mpMRI and PSMA PET scans. While this approach offers some benefits, including fewer procedural risks, it sparks important debates about accuracy, patient safety, and treatment planning. keep reading

Not all prostate biopsies are the same. Traditional methods can require more needles and carry higher risks. In-bore MRI guidance offers a safer, more precise alternative—helping doctors target aggressive cancers with confidence while reducing unnecessary complications. keep reading

Not all biopsies are created equal. When it comes to planning radiation treatment, real-time MRI guidance makes all the difference. Learn how this advanced approach helps doctors target cancer more precisely and reduce the risk of prostate cancer returning. keep reading

Should every man on active surveillance be monitored the same way? New evidence suggests genetics may hold the answer. Polygenic risk scores could one day refine prostate cancer protocols, helping patients get care that matches their unique risk. keep reading